Zava operates a telehealth service that uses patient-filled online medical questionnaires reviewed by an in-house clinical team to deliver remote consultations, prescriptions and test kits by post or via pharmacy collection. The company emphasizes human clinicians over AI or video, arguing its written questionnaire mirrors GP questioning and often yields more thorough patient responses. Founded in 2010, Zava has provided three million paid consultations since 2011, including one million in 2018, and reports almost 100,000 monthly users across six European markets (UK, Germany, France, Austria, Switzerland and Ireland). The startup remained profitable until the end of 2018 and currently employs a clinical team of more than 20 doctors, pharmacists and healthcare professionals, with plans to grow headcount. Zava intends to expand into additional European markets and pursue partnerships or contracts with state healthcare systems (including pitches to the NHS and routes in France and Germany), while launching dozens of new services focused on women’s health, new test kits and mental health. Its revenue mix to date has come from direct paid services, insurer partnerships and pharmacy collaborations, and the company plans a dual-track model in some markets combining paid consultations with free-at-point-of-care access via public healthcare contracts.

Total raised

$32M

Funding rounds

1

Latest round

Series A

Latest activity

Jun 2019